Almirall + Evotec = first-in-class dermatological therapies
Almirall S.A. and Evotec AG have entered into a research collaboration to develop first-in-class therapies for debilitating dermatology diseases.
Author: OI Team
Posts by OI Team
Almirall seeks novel targets for skin health
We provide research funding for work on novel targets and concepts which may form the basis for new medicines in dermatological diseases.
